PANACEA ACQUISITION CORP II's ticker is PANA and the CUSIP is G6882C106. A total of 47 filers reported holding PANACEA ACQUISITION CORP II in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIT CAPITAL PARTNERS PLC | 900,000 | $8,766,000 | 3.64% |
| MYDA Advisors LLC | 580,000 | $5,655,000 | 2.23% |
| 683 Capital Management, LLC | 1,480,000 | $14,430,000 | 0.77% |
| Sage Rock Capital Management LP | 382,500 | $3,729,000 | 0.67% |
| Bain Capital Life Sciences Investors, LLC | 500,000 | $4,875,000 | 0.47% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,638,750 | $16,027,000 | 0.37% |
| Boxer Capital, LLC | 500,000 | $4,875,000 | 0.25% |
| MAVERICK CAPITAL LTD | 1,385,250 | $13,506,000 | 0.24% |
| Governors Lane LP | 250,000 | $2,441,000 | 0.18% |
| Greenlight Capital | 275,000 | $2,681,000 | 0.17% |